About Phastar

PHASTAR works with small and large biotechnology, pharmaceutical and medical device companies to provide statistical consulting, analysis and reporting, data management and data science services. Our top priority is the quality of our work and ensuring that you are given the best statistical advice, that your clinical data is analysed optimally and that we get it right for you first time, every time.

There are lots of different ways to analyse a set of data. We can advise on how to get the most out of your data. We at PHASTAR believe that statistics is an art!

We can work with our own internal systems and processes or seamlessly incorporate with your teams. We can manage and deliver whole clinical trial programmes or give you advice on a trial you are planning.

Our Vision

Our vision is to become the supplier of choice for statistics, programming, data management and data science to the pharma and biotech sectors, by delivering quality advice and results, on time and on budget.


PHASTAR Founder and CEO Kevin Kane began his career in the pharmaceutical industry in 1990. After a number of years in a variety of statistical positions of increasing responsibility, Kevin hired two other statisticians to join him in 2007 and with that, PHASTAR was born. Due to PHASTAR’s reputation for outstanding quality, demand for our work has steadily increased. In 2012 we moved to larger premises in Chiswick, West London (UK) and have since established four additional UK offices and offices in the US (North Carolina, Boston and San Diego), Australia, Kenya and Japan.


PHASTAR’s primary focus is the quality of the statistical advice and clinical trial reports that we produce. At PHASTAR, we do things differently. We have a unique approach to the analysis of data, "The PHASTAR Discipline", that all team members are trained in. Additionally, we have tried and tested operational measures in place to ensure that the vast experience and technical capabilities of our global team are leveraged into every single report that we produce.